Barclays Adjusts Price Target on Henry Schein to $100 From $86

Barclays has adjusted its price target for Henry Schein (HSIC) to $100, up from the previous $86. This change reflects recent analyst activity around the company, which specializes in distributing healthcare products and services, primarily dental and medical equipment. The adjustment comes amid other recent price target changes from various financial institutions for Henry Schein.